APO Research
Talk to an analyst

APO RESEARCH · REPORT

ADCC Enhanced Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global ADCC Enhanced Antibody Market Analysis and Forecast 2026-2032

30 December 2025197 pages

Choose your research edition.

Industry ResearchADCC Enhanced Antibody Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal ADCC Enhanced Antibody Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal ADCC Enhanced Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ADCC Enhanced Antibody Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal ADCC Enhanced Antibody Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global ADCC Enhanced Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for ADCC Enhanced Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for ADCC Enhanced Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for ADCC Enhanced Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for ADCC Enhanced Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of ADCC Enhanced Antibody include C.H. Boehringer Sohn, Daiichi Sankyo, Jazz Pharmaceuticals, MacroGenics, Merus NV, Novartis AG, Puma Biotechnology, Roche Holding AG and Takeda Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for ADCC Enhanced Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of ADCC Enhanced Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for ADCC Enhanced Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the ADCC Enhanced Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global ADCC Enhanced Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for ADCC Enhanced Antibody sales, projected growth trends, production technology, application and end-user industry.

ADCC Enhanced Antibody Segment by Company

C.H. Boehringer Sohn

Daiichi Sankyo

Jazz Pharmaceuticals

MacroGenics

Merus NV

Novartis AG

Puma Biotechnology

Roche Holding AG

Takeda Pharmaceutical

Dizal (Jiangsu) Pharmaceutical

Hengrui Medicine

Pfizer

RemeGen Biopharma

Sansheng Guojian

ADCC Enhanced Antibody Segment by Type

Fc Fusion Protein

Monospecific Antibody

Polyspecific Antibody

Antibody Fusion Protein

ADCC Enhanced Antibody Segment by Application

Hospital

Clinic

Others

ADCC Enhanced Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ADCC Enhanced Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ADCC Enhanced Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ADCC Enhanced Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of ADCC Enhanced Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of ADCC Enhanced Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ADCC Enhanced Antibody sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global ADCC Enhanced Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fc Fusion Protein Major Manufacturers Table 3. Monospecific Antibody Major Manufacturers Table 4. Polyspecific Antibody Major Manufacturers Table 5. Antibody Fusion Protein Major Manufacturers Table 6. Global ADCC Enhanced Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. ADCC Enhanced Antibody Industry Trends Table 11. ADCC Enhanced Antibody Industry Drivers Table 12. ADCC Enhanced Antibody Industry Opportunities and Challenges Table 13. ADCC Enhanced Antibody Industry Restraints Table 14. Global ADCC Enhanced Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global ADCC Enhanced Antibody Revenue by Region (2021-2026) & (US$ Million) Table 16. Global ADCC Enhanced Antibody Revenue by Region (2027-2032) & (US$ Million) Table 17. Global ADCC Enhanced Antibody Revenue Market Share by Region (2021-2026) Table 18. Global ADCC Enhanced Antibody Revenue Market Share by Region (2027-2032) Table 19. Global ADCC Enhanced Antibody Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 20. Global ADCC Enhanced Antibody Sales by Region (2021-2026) & (Units) Table 21. Global ADCC Enhanced Antibody Sales by Region (2027-2032) & (Units) Table 22. Global ADCC Enhanced Antibody Sales Market Share by Region (2021-2026) Table 23. Global ADCC Enhanced Antibody Sales Market Share by Region (2027-2032) Table 24. Global ADCC Enhanced Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global ADCC Enhanced Antibody Revenue Market Share by Manufacturers (2021-2026) Table 26. Global ADCC Enhanced Antibody Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global ADCC Enhanced Antibody Sales Market Share by Manufacturers (2021-2026) Table 28. Global ADCC Enhanced Antibody Sales Price (K US$/Unit) of Manufacturers (2021-2026) Table 29. Global ADCC Enhanced Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global ADCC Enhanced Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global ADCC Enhanced Antibody Manufacturers, Product Type & Application Table 32. Global ADCC Enhanced Antibody Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global ADCC Enhanced Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global ADCC Enhanced Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global ADCC Enhanced Antibody Revenue by Type (2021-2026) & (US$ Million) Table 37. Global ADCC Enhanced Antibody Revenue by Type (2027-2032) & (US$ Million) Table 38. Global ADCC Enhanced Antibody Revenue Market Share by Type (2021-2026) Table 39. Global ADCC Enhanced Antibody Revenue Market Share by Type (2027-2032) Table 40. Global ADCC Enhanced Antibody Sales by Type 2021 VS 2025 VS 2032 (Units) Table 41. Global ADCC Enhanced Antibody Sales by Type (2021-2026) & (Units) Table 42. Global ADCC Enhanced Antibody Sales by Type (2027-2032) & (Units) Table 43. Global ADCC Enhanced Antibody Sales Market Share by Type (2021-2026) Table 44. Global ADCC Enhanced Antibody Sales Market Share by Type (2027-2032) Table 45. Global ADCC Enhanced Antibody Price by Type (2021-2026) & (K US$/Unit) Table 46. Global ADCC Enhanced Antibody Price by Type (2027-2032) & (K US$/Unit) Table 47. Global ADCC Enhanced Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global ADCC Enhanced Antibody Revenue by Application (2021-2026) & (US$ Million) Table 49. Global ADCC Enhanced Antibody Revenue by Application (2027-2032) & (US$ Million) Table 50. Global ADCC Enhanced Antibody Revenue Market Share by Application (2021-2026) Table 51. Global ADCC Enhanced Antibody Revenue Market Share by Application (2027-2032) Table 52. Global ADCC Enhanced Antibody Sales by Application 2021 VS 2025 VS 2032 (Units) Table 53. Global ADCC Enhanced Antibody Sales by Application (2021-2026) & (Units) Table 54. Global ADCC Enhanced Antibody Sales by Application (2027-2032) & (Units) Table 55. Global ADCC Enhanced Antibody Sales Market Share by Application (2021-2026) Table 56. Global ADCC Enhanced Antibody Sales Market Share by Application (2027-2032) Table 57. Global ADCC Enhanced Antibody Price by Application (2021-2026) & (K US$/Unit) Table 58. Global ADCC Enhanced Antibody Price by Application (2027-2032) & (K US$/Unit) Table 59. C.H. Boehringer Sohn Company Information Table 60. C.H. Boehringer Sohn Business Overview Table 61. C.H. Boehringer Sohn ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 62. C.H. Boehringer Sohn ADCC Enhanced Antibody Product Portfolio Table 63. C.H. Boehringer Sohn Recent Development Table 64. Daiichi Sankyo Company Information Table 65. Daiichi Sankyo Business Overview Table 66. Daiichi Sankyo ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 67. Daiichi Sankyo ADCC Enhanced Antibody Product Portfolio Table 68. Daiichi Sankyo Recent Development Table 69. Jazz Pharmaceuticals Company Information Table 70. Jazz Pharmaceuticals Business Overview Table 71. Jazz Pharmaceuticals ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 72. Jazz Pharmaceuticals ADCC Enhanced Antibody Product Portfolio Table 73. Jazz Pharmaceuticals Recent Development Table 74. MacroGenics Company Information Table 75. MacroGenics Business Overview Table 76. MacroGenics ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 77. MacroGenics ADCC Enhanced Antibody Product Portfolio Table 78. MacroGenics Recent Development Table 79. Merus NV Company Information Table 80. Merus NV Business Overview Table 81. Merus NV ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 82. Merus NV ADCC Enhanced Antibody Product Portfolio Table 83. Merus NV Recent Development Table 84. Novartis AG Company Information Table 85. Novartis AG Business Overview Table 86. Novartis AG ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 87. Novartis AG ADCC Enhanced Antibody Product Portfolio Table 88. Novartis AG Recent Development Table 89. Puma Biotechnology Company Information Table 90. Puma Biotechnology Business Overview Table 91. Puma Biotechnology ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 92. Puma Biotechnology ADCC Enhanced Antibody Product Portfolio Table 93. Puma Biotechnology Recent Development Table 94. Roche Holding AG Company Information Table 95. Roche Holding AG Business Overview Table 96. Roche Holding AG ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 97. Roche Holding AG ADCC Enhanced Antibody Product Portfolio Table 98. Roche Holding AG Recent Development Table 99. Takeda Pharmaceutical Company Information Table 100. Takeda Pharmaceutical Business Overview Table 101. Takeda Pharmaceutical ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 102. Takeda Pharmaceutical ADCC Enhanced Antibody Product Portfolio Table 103. Takeda Pharmaceutical Recent Development Table 104. Dizal (Jiangsu) Pharmaceutical Company Information Table 105. Dizal (Jiangsu) Pharmaceutical Business Overview Table 106. Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 107. Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Product Portfolio Table 108. Dizal (Jiangsu) Pharmaceutical Recent Development Table 109. Hengrui Medicine Company Information Table 110. Hengrui Medicine Business Overview Table 111. Hengrui Medicine ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 112. Hengrui Medicine ADCC Enhanced Antibody Product Portfolio Table 113. Hengrui Medicine Recent Development Table 114. Pfizer Company Information Table 115. Pfizer Business Overview Table 116. Pfizer ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 117. Pfizer ADCC Enhanced Antibody Product Portfolio Table 118. Pfizer Recent Development Table 119. RemeGen Biopharma Company Information Table 120. RemeGen Biopharma Business Overview Table 121. RemeGen Biopharma ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 122. RemeGen Biopharma ADCC Enhanced Antibody Product Portfolio Table 123. RemeGen Biopharma Recent Development Table 124. Sansheng Guojian Company Information Table 125. Sansheng Guojian Business Overview Table 126. Sansheng Guojian ADCC Enhanced Antibody Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 127. Sansheng Guojian ADCC Enhanced Antibody Product Portfolio Table 128. Sansheng Guojian Recent Development Table 129. North America ADCC Enhanced Antibody Revenue by Type (2021-2026) & (US$ Million) Table 130. North America ADCC Enhanced Antibody Revenue by Type (2027-2032) & (US$ Million) Table 131. North America ADCC Enhanced Antibody Sales by Type (2021-2026) & (Units) Table 132. North America ADCC Enhanced Antibody Sales by Type (2027-2032) & (Units) Table 133. North America ADCC Enhanced Antibody Sales Price by Type (2021-2026) & (K US$/Unit) Table 134. North America ADCC Enhanced Antibody Sales Price by Type (2027-2032) & (K US$/Unit) Table 135. North America ADCC Enhanced Antibody Revenue by Application (2021-2026) & (US$ Million) Table 136. North America ADCC Enhanced Antibody Revenue by Application (2027-2032) & (US$ Million) Table 137. North America ADCC Enhanced Antibody Sales by Application (2021-2026) & (Units) Table 138. North America ADCC Enhanced Antibody Sales by Application (2027-2032) & (Units) Table 139. North America ADCC Enhanced Antibody Sales Price by Application (2021-2026) & (K US$/Unit) Table 140. North America ADCC Enhanced Antibody Sales Price by Application (2027-2032) & (K US$/Unit) Table 141. North America ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America ADCC Enhanced Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. North America ADCC Enhanced Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. North America ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 145. North America ADCC Enhanced Antibody Sales by Country (2021-2026) & (Units) Table 146. North America ADCC Enhanced Antibody Sales by Country (2027-2032) & (Units) Table 147. North America ADCC Enhanced Antibody Sales Price by Country (2021-2026) & (K US$/Unit) Table 148. North America ADCC Enhanced Antibody Sales Price by Country (2027-2032) & (K US$/Unit) Table 149. United States ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 150. Canada ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 151. Europe ADCC Enhanced Antibody Revenue by Type (2021-2026) & (US$ Million) Table 152. Europe ADCC Enhanced Antibody Revenue by Type (2027-2032) & (US$ Million) Table 153. Europe ADCC Enhanced Antibody Sales by Type (2021-2026) & (Units) Table 154. Europe ADCC Enhanced Antibody Sales by Type (2027-2032) & (Units) Table 155. Europe ADCC Enhanced Antibody Sales Price by Type (2021-2026) & (K US$/Unit) Table 156. Europe ADCC Enhanced Antibody Sales Price by Type (2027-2032) & (K US$/Unit) Table 157. Europe ADCC Enhanced Antibody Revenue by Application (2021-2026) & (US$ Million) Table 158. Europe ADCC Enhanced Antibody Revenue by Application (2027-2032) & (US$ Million) Table 159. Europe ADCC Enhanced Antibody Sales by Application (2021-2026) & (Units) Table 160. Europe ADCC Enhanced Antibody Sales by Application (2027-2032) & (Units) Table 161. Europe ADCC Enhanced Antibody Sales Price by Application (2021-2026) & (K US$/Unit) Table 162. Europe ADCC Enhanced Antibody Sales Price by Application (2027-2032) & (K US$/Unit) Table 163. Europe ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe ADCC Enhanced Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Europe ADCC Enhanced Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Europe ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 167. Europe ADCC Enhanced Antibody Sales by Country (2021-2026) & (Units) Table 168. Europe ADCC Enhanced Antibody Sales by Country (2027-2032) & (Units) Table 169. Europe ADCC Enhanced Antibody Sales Price by Country (2021-2026) & (K US$/Unit) Table 170. Europe ADCC Enhanced Antibody Sales Price by Country (2027-2032) & (K US$/Unit) Table 171. Germany ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 172. France ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 173. U.K. ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 174. Italy ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 175. Netherlands ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 176. China ADCC Enhanced Antibody Revenue by Type (2021-2026) & (US$ Million) Table 177. China ADCC Enhanced Antibody Revenue by Type (2027-2032) & (US$ Million) Table 178. China ADCC Enhanced Antibody Sales by Type (2021-2026) & (Units) Table 179. China ADCC Enhanced Antibody Sales by Type (2027-2032) & (Units) Table 180. China ADCC Enhanced Antibody Sales Price by Type (2021-2026) & (K US$/Unit) Table 181. China ADCC Enhanced Antibody Sales Price by Type (2027-2032) & (K US$/Unit) Table 182. China ADCC Enhanced Antibody Revenue by Application (2021-2026) & (US$ Million) Table 183. China ADCC Enhanced Antibody Revenue by Application (2027-2032) & (US$ Million) Table 184. China ADCC Enhanced Antibody Sales by Application (2021-2026) & (Units) Table 185. China ADCC Enhanced Antibody Sales by Application (2027-2032) & (Units) Table 186. China ADCC Enhanced Antibody Sales Price by Application (2021-2026) & (K US$/Unit) Table 187. China ADCC Enhanced Antibody Sales Price by Application (2027-2032) & (K US$/Unit) Table 188. Asia ADCC Enhanced Antibody Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia ADCC Enhanced Antibody Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia ADCC Enhanced Antibody Sales by Type (2021-2026) & (Units) Table 191. Asia ADCC Enhanced Antibody Sales by Type (2027-2032) & (Units) Table 192. Asia ADCC Enhanced Antibody Sales Price by Type (2021-2026) & (K US$/Unit) Table 193. Asia ADCC Enhanced Antibody Sales Price by Type (2027-2032) & (K US$/Unit) Table 194. Asia ADCC Enhanced Antibody Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia ADCC Enhanced Antibody Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia ADCC Enhanced Antibody Sales by Application (2021-2026) & (Units) Table 197. Asia ADCC Enhanced Antibody Sales by Application (2027-2032) & (Units) Table 198. Asia ADCC Enhanced Antibody Sales Price by Application (2021-2026) & (K US$/Unit) Table 199. Asia ADCC Enhanced Antibody Sales Price by Application (2027-2032) & (K US$/Unit) Table 200. Asia ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia ADCC Enhanced Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia ADCC Enhanced Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 204. Asia ADCC Enhanced Antibody Sales by Country (2021-2026) & (Units) Table 205. Asia ADCC Enhanced Antibody Sales by Country (2027-2032) & (Units) Table 206. Asia ADCC Enhanced Antibody Sales Price by Country (2021-2026) & (K US$/Unit) Table 207. Asia ADCC Enhanced Antibody Sales Price by Country (2027-2032) & (K US$/Unit) Table 208. Japan ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 209. South Korea ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 210. India ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 211. Australia ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 212. China Taiwan ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 214. SAMEA ADCC Enhanced Antibody Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA ADCC Enhanced Antibody Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA ADCC Enhanced Antibody Sales by Type (2021-2026) & (Units) Table 217. SAMEA ADCC Enhanced Antibody Sales by Type (2027-2032) & (Units) Table 218. SAMEA ADCC Enhanced Antibody Sales Price by Type (2021-2026) & (K US$/Unit) Table 219. SAMEA ADCC Enhanced Antibody Sales Price by Type (2027-2032) & (K US$/Unit) Table 220. SAMEA ADCC Enhanced Antibody Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA ADCC Enhanced Antibody Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA ADCC Enhanced Antibody Sales by Application (2021-2026) & (Units) Table 223. SAMEA ADCC Enhanced Antibody Sales by Application (2027-2032) & (Units) Table 224. SAMEA ADCC Enhanced Antibody Sales Price by Application (2021-2026) & (K US$/Unit) Table 225. SAMEA ADCC Enhanced Antibody Sales Price by Application (2027-2032) & (K US$/Unit) Table 226. SAMEA ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA ADCC Enhanced Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA ADCC Enhanced Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 230. SAMEA ADCC Enhanced Antibody Sales by Country (2021-2026) & (Units) Table 231. SAMEA ADCC Enhanced Antibody Sales by Country (2027-2032) & (Units) Table 232. SAMEA ADCC Enhanced Antibody Sales Price by Country (2021-2026) & (K US$/Unit) Table 233. SAMEA ADCC Enhanced Antibody Sales Price by Country (2027-2032) & (K US$/Unit) Table 234. Brazil ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 235. Argentina ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 236. Chile ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 237. Colombia ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 238. Peru ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 240. Israel ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 241. UAE ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 242. Turkey ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 243. Iran ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 244. Egypt ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. ADCC Enhanced Antibody Distributors List Table 248. ADCC Enhanced Antibody Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. ADCC Enhanced Antibody Image Figure 2. Global ADCC Enhanced Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ADCC Enhanced Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fc Fusion Protein Image Figure 5. Monospecific Antibody Image Figure 6. Polyspecific Antibody Image Figure 7. Antibody Fusion Protein Image Figure 8. Global ADCC Enhanced Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global ADCC Enhanced Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global ADCC Enhanced Antibody Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global ADCC Enhanced Antibody Revenue (2021-2032) & (US$ Million) Figure 15. Global ADCC Enhanced Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global ADCC Enhanced Antibody Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global ADCC Enhanced Antibody Revenue Market Share by Region (2021-2032) Figure 18. Global ADCC Enhanced Antibody Sales (2021-2032) & (Units) Figure 19. Global ADCC Enhanced Antibody Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 20. Global ADCC Enhanced Antibody Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico ADCC Enhanced Antibody Sales YoY (2021-2032) & (Units) Figure 22. Europe ADCC Enhanced Antibody Sales YoY (2021-2032) & (Units) Figure 23. China ADCC Enhanced Antibody Sales YoY (2021-2032) & (Units) Figure 24. Asia (Excluding China) ADCC Enhanced Antibody Sales YoY (2021-2032) & (Units) Figure 25. South America, Middle East and Africa ADCC Enhanced Antibody Sales YoY (2021-2032) & (Units) Figure 26. Global ADCC Enhanced Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global ADCC Enhanced Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global ADCC Enhanced Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global ADCC Enhanced Antibody Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global ADCC Enhanced Antibody Revenue Market Share by Type (2021-2032) Figure 32. Global ADCC Enhanced Antibody Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 33. Global ADCC Enhanced Antibody Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global ADCC Enhanced Antibody Sales Market Share by Type (2021-2032) Figure 35. Global ADCC Enhanced Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global ADCC Enhanced Antibody Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global ADCC Enhanced Antibody Revenue Market Share by Application (2021-2032) Figure 38. Global ADCC Enhanced Antibody Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 39. Global ADCC Enhanced Antibody Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global ADCC Enhanced Antibody Sales Market Share by Application (2021-2032) Figure 41. North America ADCC Enhanced Antibody Revenue Share by Type (2021-2032) Figure 42. North America ADCC Enhanced Antibody Sales Share by Type (2021-2032) Figure 43. North America ADCC Enhanced Antibody Revenue Share by Application (2021-2032) Figure 44. North America ADCC Enhanced Antibody Sales Share by Application (2021-2032) Figure 45. North America ADCC Enhanced Antibody Revenue Share by Country (2021-2032) Figure 46. North America ADCC Enhanced Antibody Sales Share by Country (2021-2032) Figure 47. Europe ADCC Enhanced Antibody Revenue Share by Type (2021-2032) Figure 48. Europe ADCC Enhanced Antibody Sales Share by Type (2021-2032) Figure 49. Europe ADCC Enhanced Antibody Revenue Share by Application (2021-2032) Figure 50. Europe ADCC Enhanced Antibody Sales Share by Application (2021-2032) Figure 51. Europe ADCC Enhanced Antibody Revenue Share by Country (2021-2032) Figure 52. Europe ADCC Enhanced Antibody Sales Share by Country (2021-2032) Figure 53. China ADCC Enhanced Antibody Revenue Share by Type (2021-2032) Figure 54. China ADCC Enhanced Antibody Sales Share by Type (2021-2032) Figure 55. China ADCC Enhanced Antibody Revenue Share by Application (2021-2032) Figure 56. China ADCC Enhanced Antibody Sales Share by Application (2021-2032) Figure 57. Asia ADCC Enhanced Antibody Revenue Share by Type (2021-2032) Figure 58. Asia ADCC Enhanced Antibody Sales Share by Type (2021-2032) Figure 59. Asia ADCC Enhanced Antibody Revenue Share by Application (2021-2032) Figure 60. Asia ADCC Enhanced Antibody Sales Share by Application (2021-2032) Figure 61. Asia ADCC Enhanced Antibody Revenue Share by Country (2021-2032) Figure 62. Asia ADCC Enhanced Antibody Sales Share by Country (2021-2032) Figure 63. SAMEA ADCC Enhanced Antibody Revenue Share by Type (2021-2032) Figure 64. SAMEA ADCC Enhanced Antibody Sales Share by Type (2021-2032) Figure 65. SAMEA ADCC Enhanced Antibody Revenue Share by Application (2021-2032) Figure 66. SAMEA ADCC Enhanced Antibody Sales Share by Application (2021-2032) Figure 67. SAMEA ADCC Enhanced Antibody Revenue Share by Country (2021-2032) Figure 68. SAMEA ADCC Enhanced Antibody Sales Share by Country (2021-2032) Figure 69. ADCC Enhanced Antibody Value Chain Figure 70. Manufacturing Cost Structure Figure 71. ADCC Enhanced Antibody Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Fc Fusion Protein
  • Monospecific Antibody
  • Polyspecific Antibody
  • Antibody Fusion Protein
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • C.H. Boehringer Sohn
  • Daiichi Sankyo
  • Jazz Pharmaceuticals
  • MacroGenics
  • Merus NV
  • Novartis AG
  • Puma Biotechnology
  • Roche Holding AG
  • Takeda Pharmaceutical
  • Dizal (Jiangsu) Pharmaceutical
  • Hengrui Medicine
  • Pfizer
  • RemeGen Biopharma
  • Sansheng Guojian

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 ADCC Enhanced Antibody Market by Type
  3. 1.2.1 Global ADCC Enhanced Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fc Fusion Protein
  5. 1.2.3 Monospecific Antibody
  6. 1.2.4 Polyspecific Antibody
  7. 1.2.5 Antibody Fusion Protein
  8. 1.3 ADCC Enhanced Antibody Market by Application
  9. 1.3.1 Global ADCC Enhanced Antibody Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 ADCC Enhanced Antibody Market Dynamics
  1. 2.1 ADCC Enhanced Antibody Industry Trends
  2. 2.2 ADCC Enhanced Antibody Industry Drivers
  3. 2.3 ADCC Enhanced Antibody Industry Opportunities and Challenges
  4. 2.4 ADCC Enhanced Antibody Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global ADCC Enhanced Antibody Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global ADCC Enhanced Antibody Revenue by Region
  3. 3.2.1 Global ADCC Enhanced Antibody Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global ADCC Enhanced Antibody Revenue by Region (2021-2026)
  5. 3.2.3 Global ADCC Enhanced Antibody Revenue by Region (2027-2032)
  6. 3.2.4 Global ADCC Enhanced Antibody Revenue Market Share by Region (2021-2032)
  7. 3.3 Global ADCC Enhanced Antibody Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global ADCC Enhanced Antibody Sales by Region
  9. 3.4.1 Global ADCC Enhanced Antibody Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global ADCC Enhanced Antibody Sales by Region (2021-2026)
  11. 3.4.3 Global ADCC Enhanced Antibody Sales by Region (2027-2032)
  12. 3.4.4 Global ADCC Enhanced Antibody Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global ADCC Enhanced Antibody Revenue by Manufacturers
  2. 4.1.1 Global ADCC Enhanced Antibody Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global ADCC Enhanced Antibody Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global ADCC Enhanced Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global ADCC Enhanced Antibody Sales by Manufacturers
  6. 4.2.1 Global ADCC Enhanced Antibody Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global ADCC Enhanced Antibody Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global ADCC Enhanced Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global ADCC Enhanced Antibody Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global ADCC Enhanced Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global ADCC Enhanced Antibody Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global ADCC Enhanced Antibody Manufacturers, Product Type & Application
  13. 4.7 Global ADCC Enhanced Antibody Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global ADCC Enhanced Antibody Market CR5 and HHI
  16. 4.8.2 2025 ADCC Enhanced Antibody Tier 1, Tier 2, and Tier 3
5 ADCC Enhanced Antibody Market by Type
  1. 5.1 Global ADCC Enhanced Antibody Revenue by Type
  2. 5.1.1 Global ADCC Enhanced Antibody Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global ADCC Enhanced Antibody Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global ADCC Enhanced Antibody Revenue Market Share by Type (2021-2032)
  5. 5.2 Global ADCC Enhanced Antibody Sales by Type
  6. 5.2.1 Global ADCC Enhanced Antibody Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global ADCC Enhanced Antibody Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global ADCC Enhanced Antibody Sales Market Share by Type (2021-2032)
  9. 5.3 Global ADCC Enhanced Antibody Price by Type
6 ADCC Enhanced Antibody Market by Application
  1. 6.1 Global ADCC Enhanced Antibody Revenue by Application
  2. 6.1.1 Global ADCC Enhanced Antibody Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global ADCC Enhanced Antibody Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global ADCC Enhanced Antibody Revenue Market Share by Application (2021-2032)
  5. 6.2 Global ADCC Enhanced Antibody Sales by Application
  6. 6.2.1 Global ADCC Enhanced Antibody Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global ADCC Enhanced Antibody Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global ADCC Enhanced Antibody Sales Market Share by Application (2021-2032)
  9. 6.3 Global ADCC Enhanced Antibody Price by Application
7 Company Profiles
  1. 7.1 C.H. Boehringer Sohn
  2. 7.1.1 C.H. Boehringer Sohn Company Information
  3. 7.1.2 C.H. Boehringer Sohn Business Overview
  4. 7.1.3 C.H. Boehringer Sohn ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 C.H. Boehringer Sohn ADCC Enhanced Antibody Product Portfolio
  6. 7.1.5 C.H. Boehringer Sohn Recent Developments
  7. 7.2 Daiichi Sankyo
  8. 7.2.1 Daiichi Sankyo Company Information
  9. 7.2.2 Daiichi Sankyo Business Overview
  10. 7.2.3 Daiichi Sankyo ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Daiichi Sankyo ADCC Enhanced Antibody Product Portfolio
  12. 7.2.5 Daiichi Sankyo Recent Developments
  13. 7.3 Jazz Pharmaceuticals
  14. 7.3.1 Jazz Pharmaceuticals Company Information
  15. 7.3.2 Jazz Pharmaceuticals Business Overview
  16. 7.3.3 Jazz Pharmaceuticals ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jazz Pharmaceuticals ADCC Enhanced Antibody Product Portfolio
  18. 7.3.5 Jazz Pharmaceuticals Recent Developments
  19. 7.4 MacroGenics
  20. 7.4.1 MacroGenics Company Information
  21. 7.4.2 MacroGenics Business Overview
  22. 7.4.3 MacroGenics ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MacroGenics ADCC Enhanced Antibody Product Portfolio
  24. 7.4.5 MacroGenics Recent Developments
  25. 7.5 Merus NV
  26. 7.5.1 Merus NV Company Information
  27. 7.5.2 Merus NV Business Overview
  28. 7.5.3 Merus NV ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merus NV ADCC Enhanced Antibody Product Portfolio
  30. 7.5.5 Merus NV Recent Developments
  31. 7.6 Novartis AG
  32. 7.6.1 Novartis AG Company Information
  33. 7.6.2 Novartis AG Business Overview
  34. 7.6.3 Novartis AG ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis AG ADCC Enhanced Antibody Product Portfolio
  36. 7.6.5 Novartis AG Recent Developments
  37. 7.7 Puma Biotechnology
  38. 7.7.1 Puma Biotechnology Company Information
  39. 7.7.2 Puma Biotechnology Business Overview
  40. 7.7.3 Puma Biotechnology ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Puma Biotechnology ADCC Enhanced Antibody Product Portfolio
  42. 7.7.5 Puma Biotechnology Recent Developments
  43. 7.8 Roche Holding AG
  44. 7.8.1 Roche Holding AG Company Information
  45. 7.8.2 Roche Holding AG Business Overview
  46. 7.8.3 Roche Holding AG ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Roche Holding AG ADCC Enhanced Antibody Product Portfolio
  48. 7.8.5 Roche Holding AG Recent Developments
  49. 7.9 Takeda Pharmaceutical
  50. 7.9.1 Takeda Pharmaceutical Company Information
  51. 7.9.2 Takeda Pharmaceutical Business Overview
  52. 7.9.3 Takeda Pharmaceutical ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Takeda Pharmaceutical ADCC Enhanced Antibody Product Portfolio
  54. 7.9.5 Takeda Pharmaceutical Recent Developments
  55. 7.10 Dizal (Jiangsu) Pharmaceutical
  56. 7.10.1 Dizal (Jiangsu) Pharmaceutical Company Information
  57. 7.10.2 Dizal (Jiangsu) Pharmaceutical Business Overview
  58. 7.10.3 Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Dizal (Jiangsu) Pharmaceutical ADCC Enhanced Antibody Product Portfolio
  60. 7.10.5 Dizal (Jiangsu) Pharmaceutical Recent Developments
  61. 7.11 Hengrui Medicine
  62. 7.11.1 Hengrui Medicine Company Information
  63. 7.11.2 Hengrui Medicine Business Overview
  64. 7.11.3 Hengrui Medicine ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hengrui Medicine ADCC Enhanced Antibody Product Portfolio
  66. 7.11.5 Hengrui Medicine Recent Developments
  67. 7.12 Pfizer
  68. 7.12.1 Pfizer Company Information
  69. 7.12.2 Pfizer Business Overview
  70. 7.12.3 Pfizer ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Pfizer ADCC Enhanced Antibody Product Portfolio
  72. 7.12.5 Pfizer Recent Developments
  73. 7.13 RemeGen Biopharma
  74. 7.13.1 RemeGen Biopharma Company Information
  75. 7.13.2 RemeGen Biopharma Business Overview
  76. 7.13.3 RemeGen Biopharma ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 RemeGen Biopharma ADCC Enhanced Antibody Product Portfolio
  78. 7.13.5 RemeGen Biopharma Recent Developments
  79. 7.14 Sansheng Guojian
  80. 7.14.1 Sansheng Guojian Company Information
  81. 7.14.2 Sansheng Guojian Business Overview
  82. 7.14.3 Sansheng Guojian ADCC Enhanced Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sansheng Guojian ADCC Enhanced Antibody Product Portfolio
  84. 7.14.5 Sansheng Guojian Recent Developments
8 North America
  1. 8.1 North America ADCC Enhanced Antibody Market Size by Type
  2. 8.1.1 North America ADCC Enhanced Antibody Revenue by Type (2021-2032)
  3. 8.1.2 North America ADCC Enhanced Antibody Sales by Type (2021-2032)
  4. 8.1.3 North America ADCC Enhanced Antibody Price by Type (2021-2032)
  5. 8.2 North America ADCC Enhanced Antibody Market Size by Application
  6. 8.2.1 North America ADCC Enhanced Antibody Revenue by Application (2021-2032)
  7. 8.2.2 North America ADCC Enhanced Antibody Sales by Application (2021-2032)
  8. 8.2.3 North America ADCC Enhanced Antibody Price by Application (2021-2032)
  9. 8.3 North America ADCC Enhanced Antibody Market Size by Country
  10. 8.3.1 North America ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America ADCC Enhanced Antibody Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe ADCC Enhanced Antibody Market Size by Type
  2. 9.1.1 Europe ADCC Enhanced Antibody Revenue by Type (2021-2032)
  3. 9.1.2 Europe ADCC Enhanced Antibody Sales by Type (2021-2032)
  4. 9.1.3 Europe ADCC Enhanced Antibody Price by Type (2021-2032)
  5. 9.2 Europe ADCC Enhanced Antibody Market Size by Application
  6. 9.2.1 Europe ADCC Enhanced Antibody Revenue by Application (2021-2032)
  7. 9.2.2 Europe ADCC Enhanced Antibody Sales by Application (2021-2032)
  8. 9.2.3 Europe ADCC Enhanced Antibody Price by Application (2021-2032)
  9. 9.3 Europe ADCC Enhanced Antibody Market Size by Country
  10. 9.3.1 Europe ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe ADCC Enhanced Antibody Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China ADCC Enhanced Antibody Market Size by Type
  2. 10.1.1 China ADCC Enhanced Antibody Revenue by Type (2021-2032)
  3. 10.1.2 China ADCC Enhanced Antibody Sales by Type (2021-2032)
  4. 10.1.3 China ADCC Enhanced Antibody Price by Type (2021-2032)
  5. 10.2 China ADCC Enhanced Antibody Market Size by Application
  6. 10.2.1 China ADCC Enhanced Antibody Revenue by Application (2021-2032)
  7. 10.2.2 China ADCC Enhanced Antibody Sales by Application (2021-2032)
  8. 10.2.3 China ADCC Enhanced Antibody Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia ADCC Enhanced Antibody Market Size by Type
  2. 11.1.1 Asia ADCC Enhanced Antibody Revenue by Type (2021-2032)
  3. 11.1.2 Asia ADCC Enhanced Antibody Sales by Type (2021-2032)
  4. 11.1.3 Asia ADCC Enhanced Antibody Price by Type (2021-2032)
  5. 11.2 Asia ADCC Enhanced Antibody Market Size by Application
  6. 11.2.1 Asia ADCC Enhanced Antibody Revenue by Application (2021-2032)
  7. 11.2.2 Asia ADCC Enhanced Antibody Sales by Application (2021-2032)
  8. 11.2.3 Asia ADCC Enhanced Antibody Price by Application (2021-2032)
  9. 11.3 Asia ADCC Enhanced Antibody Market Size by Country
  10. 11.3.1 Asia ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia ADCC Enhanced Antibody Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA ADCC Enhanced Antibody Market Size by Type
  2. 12.1.1 SAMEA ADCC Enhanced Antibody Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA ADCC Enhanced Antibody Sales by Type (2021-2032)
  4. 12.1.3 SAMEA ADCC Enhanced Antibody Price by Type (2021-2032)
  5. 12.2 SAMEA ADCC Enhanced Antibody Market Size by Application
  6. 12.2.1 SAMEA ADCC Enhanced Antibody Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA ADCC Enhanced Antibody Sales by Application (2021-2032)
  8. 12.2.3 SAMEA ADCC Enhanced Antibody Price by Application (2021-2032)
  9. 12.3 SAMEA ADCC Enhanced Antibody Market Size by Country
  10. 12.3.1 SAMEA ADCC Enhanced Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA ADCC Enhanced Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA ADCC Enhanced Antibody Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 ADCC Enhanced Antibody Value Chain Analysis
  2. 13.1.1 ADCC Enhanced Antibody Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 ADCC Enhanced Antibody Production Mode & Process
  6. 13.2 ADCC Enhanced Antibody Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 ADCC Enhanced Antibody Distributors
  9. 13.2.3 ADCC Enhanced Antibody Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst